“With this latest appointment, mifepristone has a new boss but an old problem,” writes Julie F. Kay, founder and CEO of Reproductive Futures.
Back to Lifestyle
Lifestyle
September 25, 2026 at 2:39 PM
Opinion: FDA commissioner nominee Heidi Overton is ignoring the science on abortion drug
STAT News
Excerpt from STAT News.